Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets close in 3 hours 30 minutes
Straits Times Index
3,308.28
+8.28
(+0.25%)
Nikkei
38,638.67
+5.65
(+0.01%)
Hang Seng
18,011.22
-324.10
(-1.77%)
FTSE 100
8,272.46
+67.35
(+0.82%)
Bitcoin USD
64,542.68
-792.81
(-1.21%)
CMC Crypto 200
1,352.25
-30.42
(-2.20%)
Tasly Pharmaceutical Group Co., Ltd (600535.SS)
Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
13.20
+0.19
(+1.46%)
As of 01:15PM CST. Market open.
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
8,637,978
8,674,014
8,637,429
7,951,957
13,576,115
Cost of revenue
2,833,613
2,880,103
3,120,919
2,677,531
8,109,105
Gross profit
5,804,365
5,793,911
5,516,510
5,274,426
5,467,010
Operating expenses
Research development
951,087
917,269
845,344
579,527
689,331
Selling general and administrative
3,076,410
3,066,273
3,002,935
3,071,329
2,897,454
Total operating expenses
4,326,296
4,289,106
4,150,776
3,962,223
3,933,012
Operating income or loss
1,478,069
1,504,805
1,365,734
1,312,202
1,533,997
Interest expense
81,534
82,524
64,411
77,391
286,690
Income before tax
1,209,545
1,221,097
-167,632
2,723,540
1,457,053
Income tax expense
161,051
204,457
180,823
315,925
367,195
Income from continuing operations
1,048,494
1,016,640
-348,455
2,407,616
1,089,857
Net income
1,101,698
1,071,072
-264,238
2,358,865
1,125,891
Net income available to common shareholders
1,101,698
1,071,072
-264,238
2,358,865
1,125,891
Basic EPS
0.75
0.72
-0.18
1.57
0.75
Diluted EPS
0.75
0.72
-0.18
1.57
0.75
Basic average shares
1,509,035
1,487,600
1,467,991
1,502,462
1,501,188
Diluted average shares
1,509,035
1,487,600
1,467,991
1,502,462
1,501,188
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.